131 related articles for article (PubMed ID: 23850691)
21. 4-tert-Octylphenol stimulates the expression of cathepsins in human breast cancer cells and xenografted breast tumors of a mouse model via an estrogen receptor-mediated signaling pathway.
Lee HR; Choi KC
Toxicology; 2013 Feb; 304():13-20. PubMed ID: 23219593
[TBL] [Abstract][Full Text] [Related]
22. Mesenchymal stem cells from primary breast cancer tissue promote cancer proliferation and enhance mammosphere formation partially via EGF/EGFR/Akt pathway.
Yan XL; Fu CJ; Chen L; Qin JH; Zeng Q; Yuan HF; Nan X; Chen HX; Zhou JN; Lin YL; Zhang XM; Yu CZ; Yue W; Pei XT
Breast Cancer Res Treat; 2012 Feb; 132(1):153-64. PubMed ID: 21584665
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of EGFR pathway signaling and the metastatic potential of breast cancer cells by PA-MSHA mediated by type 1 fimbriae via a mannose-dependent manner.
Liu ZB; Hou YF; Zhu J; Hu DL; Jin W; Ou ZL; Di GH; Wu J; Shen ZZ; Shao ZM
Oncogene; 2010 May; 29(20):2996-3009. PubMed ID: 20228837
[TBL] [Abstract][Full Text] [Related]
24. CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome.
Idowu MO; Kmieciak M; Dumur C; Burton RS; Grimes MM; Powers CN; Manjili MH
Hum Pathol; 2012 Mar; 43(3):364-73. PubMed ID: 21835433
[TBL] [Abstract][Full Text] [Related]
25. Gene expression profiles of prostate cancer stem cells isolated by aldehyde dehydrogenase activity assay.
Nishida S; Hirohashi Y; Torigoe T; Kitamura H; Takahashi A; Masumori N; Tsukamoto T; Sato N
J Urol; 2012 Jul; 188(1):294-9. PubMed ID: 22608744
[TBL] [Abstract][Full Text] [Related]
26. Eps8 regulates cellular proliferation and migration of breast cancer.
Chen C; Liang Z; Huang W; Li X; Zhou F; Hu X; Han M; Ding X; Xiang S
Int J Oncol; 2015 Jan; 46(1):205-14. PubMed ID: 25333707
[TBL] [Abstract][Full Text] [Related]
27. ALDH1-positive cancer stem cells predict engraftment of primary breast tumors and are governed by a common stem cell program.
Charafe-Jauffret E; Ginestier C; Bertucci F; Cabaud O; Wicinski J; Finetti P; Josselin E; Adelaide J; Nguyen TT; Monville F; Jacquemier J; Thomassin-Piana J; Pinna G; Jalaguier A; Lambaudie E; Houvenaeghel G; Xerri L; Harel-Bellan A; Chaffanet M; Viens P; Birnbaum D
Cancer Res; 2013 Dec; 73(24):7290-300. PubMed ID: 24142344
[TBL] [Abstract][Full Text] [Related]
28. Biomarkers for breast cancer stem cells: the challenges ahead.
Gökmen-Polar Y; Nakshatri H; Badve S
Biomark Med; 2011 Oct; 5(5):661-71. PubMed ID: 22003917
[TBL] [Abstract][Full Text] [Related]
29. Splicing factor hnRNPA2B1 contributes to tumorigenic potential of breast cancer cells through STAT3 and ERK1/2 signaling pathway.
Hu Y; Sun Z; Deng J; Hu B; Yan W; Wei H; Jiang J
Tumour Biol; 2017 Mar; 39(3):1010428317694318. PubMed ID: 28351333
[TBL] [Abstract][Full Text] [Related]
30. GRP78 mediates radiation resistance of a stem cell-like subpopulation within the MCF-7 breast cancer cell line.
Li B; Cheng XL; Yang YP; Li ZQ
Oncol Rep; 2013 Nov; 30(5):2119-26. PubMed ID: 24002052
[TBL] [Abstract][Full Text] [Related]
31. In situ identification of putative cancer stem cells by multiplexing ALDH1, CD44, and cytokeratin identifies breast cancer patients with poor prognosis.
Neumeister V; Agarwal S; Bordeaux J; Camp RL; Rimm DL
Am J Pathol; 2010 May; 176(5):2131-8. PubMed ID: 20228222
[TBL] [Abstract][Full Text] [Related]
32. A transcriptional complex composed of ER(α), GATA3, FOXA1 and ELL3 regulates IL-20 expression in breast cancer cells.
Lee JY; Park YJ; Oh N; Kwack KB; Park KS
Oncotarget; 2017 Jun; 8(26):42752-42760. PubMed ID: 28514748
[TBL] [Abstract][Full Text] [Related]
33. [Down-regulation of Smoothened gene expression inhibits proliferation of breast cancer stem cells].
Mao J; Fan PH; Ma W; Zhang QQ; Wang B; Fan SJ; Li LH
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):262-6. PubMed ID: 23928535
[TBL] [Abstract][Full Text] [Related]
34. Identification, cloning, expression, and biochemical characterization of the testis-specific RNA polymerase II elongation factor ELL3.
Miller T; Williams K; Johnstone RW; Shilatifard A
J Biol Chem; 2000 Oct; 275(41):32052-6. PubMed ID: 10882741
[TBL] [Abstract][Full Text] [Related]
35. CD44 regulates cell proliferation, migration, and invasion via modulation of c-Src transcription in human breast cancer cells.
Nam K; Oh S; Lee KM; Yoo SA; Shin I
Cell Signal; 2015 Sep; 27(9):1882-94. PubMed ID: 25979842
[TBL] [Abstract][Full Text] [Related]
36. FSIP1 binds HER2 directly to regulate breast cancer growth and invasiveness.
Liu T; Zhang H; Sun L; Zhao D; Liu P; Yan M; Zaidi N; Izadmehr S; Gupta A; Abu-Amer W; Luo M; Yang J; Ou X; Wang Y; Bai X; Wang Y; New MI; Zaidi M; Yuen T; Liu C
Proc Natl Acad Sci U S A; 2017 Jul; 114(29):7683-7688. PubMed ID: 28674022
[TBL] [Abstract][Full Text] [Related]
37. Chemotherapy triggers HIF-1-dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype.
Lu H; Samanta D; Xiang L; Zhang H; Hu H; Chen I; Bullen JW; Semenza GL
Proc Natl Acad Sci U S A; 2015 Aug; 112(33):E4600-9. PubMed ID: 26229077
[TBL] [Abstract][Full Text] [Related]
38. KIF26B promotes cell proliferation and migration through the FGF2/ERK signaling pathway in breast cancer.
Teng Y; Guo B; Mu X; Liu S
Biomed Pharmacother; 2018 Dec; 108():766-773. PubMed ID: 30248545
[TBL] [Abstract][Full Text] [Related]
39. The RNA Pol II elongation factor Ell3 marks enhancers in ES cells and primes future gene activation.
Lin C; Garruss AS; Luo Z; Guo F; Shilatifard A
Cell; 2013 Jan; 152(1-2):144-56. PubMed ID: 23273992
[TBL] [Abstract][Full Text] [Related]
40. FOXD1 promotes breast cancer proliferation and chemotherapeutic drug resistance by targeting p27.
Zhao YF; Zhao JY; Yue H; Hu KS; Shen H; Guo ZG; Su XJ
Biochem Biophys Res Commun; 2015 Jan; 456(1):232-7. PubMed ID: 25462566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
